Surgery Partners Inc (NASDAQ: SGRY) stock closed at $30.18 on 11/14/23 after a major increase of 13.0%. The stock has risen 21.6% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
SGRY is expected to continue to be a modest Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Surgery Partners has a current Value Trend Rating of C (Low Neutral). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Surgery Partners has a neutral Power Rating of 46 and a neutral Appreciation Score of 43, leading to the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment